Detecting MRD Prior to Repeat-transurethral Resection of Bladder Tumor in NMIBC

By Kyle M. Rose, MD - Last Updated: February 18, 2023

Kyle M. Rose, MD, Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center & Research Institute, describes how cell-free urinary tumor DNA is used as a strategy to detect MRD prior to repeat-transurethral resection of bladder tumors in NMIBC.

Post Tags:ASCO GU 2023-Bladder Cancer
Advertisement
Advertisement